368 related articles for article (PubMed ID: 28450532)
1. P53-miR-191-
Sharma S; Nagpal N; Ghosh PC; Kulshreshtha R
RNA; 2017 Aug; 23(8):1237-1246. PubMed ID: 28450532
[TBL] [Abstract][Full Text] [Related]
2. p53/miR-30a-5p/ SOX4 feedback loop mediates cellular proliferation, apoptosis, and migration of non-small-cell lung cancer.
Quan X; Li X; Yin Z; Ren Y; Zhou B
J Cell Physiol; 2019 Dec; 234(12):22884-22895. PubMed ID: 31124131
[TBL] [Abstract][Full Text] [Related]
3. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer via SOX4/p53 Feedback Loop.
Li D; He C; Wang J; Wang Y; Bu J; Kong X; Sun D
Oncol Res; 2018 Apr; 26(3):385-400. PubMed ID: 28653608
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-140 Inhibits Cell Proliferation in Gastric Cancer Cell Line HGC-27 by Suppressing SOX4.
Zou J; Xu Y
Med Sci Monit; 2016 Jun; 22():2243-52. PubMed ID: 27353653
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
7. miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade.
Zhang J; Su B; Gong C; Xi Q; Chao T
Biochem Biophys Res Commun; 2016 Sep; 478(1):337-342. PubMed ID: 27422604
[TBL] [Abstract][Full Text] [Related]
8. MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance.
Luan QX; Zhang BG; Li XJ; Guo MY
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4257-4265. PubMed ID: 27831649
[TBL] [Abstract][Full Text] [Related]
9. Sublytic C5b-9 Induces Glomerular Mesangial Cell Apoptosis Through miR-3546/SOX4/Survivin Axis in Rat Thy-1 Nephritis.
Yao C; He F; Liu L; Zhang Z; Zhao C; Qiu W; Zhao D; Zhang J; Xie M; Gong Y; Yu T; Xia L; Qian B; Wang Y
Cell Physiol Biochem; 2018; 49(5):1898-1917. PubMed ID: 30235450
[TBL] [Abstract][Full Text] [Related]
10. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
11. microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.
Zeng H; Wang L; Wang J; Chen T; Li H; Zhang K; Chen J; Zhen S; Tuluhong D; Li J; Wang S
Arch Biochem Biophys; 2018 Aug; 651():52-60. PubMed ID: 29802821
[TBL] [Abstract][Full Text] [Related]
12. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
13. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
14. miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1.
Wu D; Zhang J; Lu Y; Bo S; Li L; Wang L; Zhang Q; Mao J
Cancer Gene Ther; 2019 Mar; 26(3-4):74-82. PubMed ID: 30032164
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract][Full Text] [Related]
17. miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2.
Zhang Y; Xia F; Zhang F; Cui Y; Wang Q; Liu H; Wu Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):26. PubMed ID: 30665445
[TBL] [Abstract][Full Text] [Related]
18. LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.
Zhou X; Sang M; Liu W; Gao W; Xing E; Lü W; Xu Y; Fan X; Jing S; Shan B
Life Sci; 2012 Sep; 91(9-10):358-63. PubMed ID: 22906635
[TBL] [Abstract][Full Text] [Related]
19. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
Lin S; Yu L; Song X; Bi J; Jiang L; Wang Y; He M; Xiao Q; Sun M; Olopade OI; Zhao L; Wei M
Cell Death Dis; 2019 Sep; 10(9):666. PubMed ID: 31511498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
